Neurocrine Biosciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 18,380 | 0.0183% |
| State or Government | 115,811 | 0.115% |
| Individual Insiders | 1,092,324 | 1.09% |
| General Public | 5,549,801 | 5.52% |
| Institutions | 93,804,181 | 93.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.1%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 13,647,891 | US$1.9b | 2.07% | 0.03% | |||
| 9,710,328 | US$1.3b | 1.57% | 0.02% | |||
| 4,063,336 | US$558.9m | 5.91% | 0.02% | |||
| 2,430,500 | US$334.3m | -5.92% | 3.74% | |||
| 1,988,546 | US$273.5m | 25.1% | 0.4% | |||
| 1,623,124 | US$223.2m | 4.41% | 0.02% | |||
| 1,595,873 | US$219.5m | -5.91% | 0.03% | |||
| 1,551,367 | US$213.4m | -9.65% | 0.09% | |||
| 1,476,949 | US$203.1m | 25.2% | 0.02% | |||
| 1,454,062 | US$200.0m | 0% | 0.05% | |||
| 1,419,900 | US$195.3m | -47.5% | 0.41% | |||
| 1,259,744 | US$173.3m | 490% | 0.08% | |||
| 1,222,009 | US$168.1m | -0.16% | 2.23% | |||
| 1,213,313 | US$166.9m | 16.3% | 0.11% | |||
| 1,199,542 | US$165.0m | -9.67% | 0.03% | |||
| 1,196,000 | US$164.5m | -3.24% | 4.6% | |||
| 1,088,333 | US$149.7m | -2.25% | 0.2% | |||
| 1,048,000 | US$144.1m | -13.8% | 3.74% | |||
| 905,374 | US$124.5m | -5.9% | 0.02% | |||
| 896,719 | US$123.3m | -25.9% | 2.46% | |||
| 865,662 | US$119.1m | 87.7% | 0.02% | |||
| 835,833 | US$115.0m | 157% | 0.49% | |||
| 807,281 | US$111.0m | -4.28% | 0.02% | |||
| 800,000 | US$110.0m | 0% | 12.19% | |||
| 782,044 | US$107.6m | -22.9% | 0.06% |